A
ACHV
Achieve Life Sciences Inc
5.24
-0.06-1.13%After Hours: 5.13 -0.11 -2.10%19:29 05/29 EDT
OPEN/PREV CLOSE5.35/5.30
TODAY RANGE5.24-5.49
VOL1.10M
MARKET CAP537.93M
52 WEEK RANGE2.000-6.15
AVG VOL (3M)1.28M
% TURNOVER1.07%
TURNOVER--
P/E (TTM)-4.7088
% RANGE4.81%
EPS(TTM)-1.1128
P/E(FORWARD)-7.1781
P/B26.12
BVPS0.2006
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP431.01M
SHARES OUTSTANDING102.66M
NEXT EARNINGS08/05-08/10
FREE FLOAT82.25M
LOT SIZE1
EX-DATE07/31/2020
News
Press Releases
Financial Reports
Profile
Seeking Alpha·05/13 19:17
Achieve Life Sciences: 'Hold' On Expected CRL Cytisinicline And Q4 2026 NDA Resubmission
TipRanks·05/13 13:20
Lake Street Sticks to Its Buy Rating for Achieve Life Sciences (ACHV)
TipRanks·05/13 00:12
Achieve Life Sciences Charts Delayed Path to Launch
TipRanks·05/12 21:31
Achieve Life Sciences files prospectus for resale of shares by holders
NASDAQ·05/12 16:56
Achieve (ACHV) Q1 2026 Earnings Transcript
TipRanks·05/12 16:35
Achieve Life Sciences (ACHV) Gets a Buy from H.C. Wainwright
Seeking Alpha·05/12 15:42
Achieve outlines Q4 2026 NDA resubmission and 1H 2027 launch plans following $180M financing
Benzinga·05/12 13:16
Achieve Life Sciences Reports Q1 2026 Results: Full Earnings Call Transcript